uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Recombinant hirudin in clinical practice: focus on lepirudin.
(Department of Transfusion Medicine, Greifswald University, Germany)
2001 (English)In: Circulation, ISSN 0009-7322, E-ISSN 1524-4539, Vol. 103, no 10, 1479-84 p.Article in journal (Refereed) Published
Abstract [en]

Clinical applications for recombinant hirudins have been investigated for the past 10 years. The first indication for which a hirudin-lepirudin-has been approved is treatment of heparin-induced thrombocytopenia (HIT). Also, the recently completed trials for use of lepirudin in unstable angina indicate a potentially new indication. This review describes pharmacology and clinical applications of lepirudin with an emphasis on HIT and unstable angina. An overview of usage of lepirudin in acute coronary syndromes is given, as well as a summary of rare indications for lepirudin, such as extracorporeal circulation, for which comprehensive data are lacking.

Place, publisher, year, edition, pages
2001. Vol. 103, no 10, 1479-84 p.
National Category
Clinical Medicine
URN: urn:nbn:se:uu:diva-161383PubMedID: 11245656OAI: oai:DiVA.org:uu-161383DiVA: diva2:455971
Available from: 2011-11-11 Created: 2011-11-11 Last updated: 2011-11-30

Open Access in DiVA

No full text


Search in DiVA

By author/editor
Lubenow, Norbert
In the same journal
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 97 hits
ReferencesLink to record
Permanent link

Direct link